Literature DB >> 12592093

Infliximab: a promising new treatment option for ulcerated necrobiosis lipoidica.

Gerhard Kolde, J Marcus Muche, Peter Schulze, Peter Fischer, Jürgen Lichey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592093     DOI: 10.1159/000068465

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  8 in total

1.  Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients.

Authors:  Cindy Franklin; Maren Stoffels-Weindorf; Uwe Hillen; Joachim Dissemond
Journal:  Int Wound J       Date:  2013-10-07       Impact factor: 3.315

Review 2.  [Off-label use of infliximab].

Authors:  M Onder; C Salavastru; K Fritz
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

3.  [Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab].

Authors:  L Leister; A Körber; J Dissemond
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

4.  Ulcerative Necrobiosis Lipoidica: Is There a Place for Anti-TNFα Treatment?

Authors:  Rita Guedes; Inês Leite; Armando Baptista; Natividade Rocha
Journal:  Case Rep Med       Date:  2012-05-23

5.  Granulomatous skin disease with a histological pattern of palisading granuloma - an atypical facial necrobiosis lipoidica or more?

Authors:  Anna Rosińska-Więckowicz; Monika Bowszyc-Dmochowska
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

6.  Necrobiosis lipoidica diabeticorum: A case-based review of literature.

Authors:  Sunil Kumar Kota; Sruti Jammula; Siva Krishna Kota; Lalit Kumar Meher; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-07

Review 7.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

8.  The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature.

Authors:  Vijay Kumari Sandhu; Afsaneh Alavi
Journal:  SAGE Open Med Case Rep       Date:  2019-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.